Ensuring batch-to-batch consistency in particle size, drug loading efficiency, surface chemistry, and release kinetics is critical for predictable therapeutic outcomes and regulatory approval
Phase IA and Phase IB proposals were due June 29, 2026 at 11AM ET
Th1 and Th17 cytokines activate microglia, increase oxidative stress, and impair neural resilience, whereas Treg deficiency eliminates a crucial control on systemic and central inflammation, promoting a feed-forward degenerative cycle [82]
Endothelial targeting of semi-permeable polymer nanocarriers for enzyme therapies
Your body produces it on its own, but production declines significantly with age, from roughly 200 ng/mL at age 20 to around 80 ng/mL by age 60